Cannabis Law Report

DECEMBER 14, 2021

During the Phase 1 trial, minimal adverse events were reported, and IGC-AD1 was tolerated with no safety concerns identified by an independent Data Safety Monitoring Board. The primary endpoint of our Phase 1 clinical trial was to test and demonstrate safety and tolerability. The average age was 80.9 In addition, 66.7%

Clinical Trials 52

Clinical Trials Safety Data Patients 52

Medicinal Genomics

FEBRUARY 8, 2024

The subsequent investigation did not determine a definitive cause for the condition; however, the report did mention investigators tested the air for levels of endotoxin, “a pro-inflammatory contaminant associated with gram-negative bacterial growth on organic materials such as cannabis flower”.

Treatment 98

Treatment Dispensary Safety Cannabis 98

Illinois News Joint

SEPTEMBER 30, 2023

The summary continued, “IDFPR strives to put social equity at the forefront of our regulatory practices” and “IDFPR stands ready to continue issuing dispensary licenses and is committed to promoting social equity, safety, and growth into the regulated cannabis market.” To find cannabis-friendly events in Illinois, visit here.

Seed-To-Sale 90

Seed-To-Sale Dispensary Advocacy Conditions 90

Cannabis Law Report

MAY 31, 2022

The complaints also allege that Curaleaf failed to warn or properly instruct the plaintiffs about the condition of the Select CBD Drops. Each assert one count for products liability arising out of the allegation that Curaleaf was negligent by making its Select CBD Drops with THC and by not having the required THC warning label.

Supply Chain 52

Supply Chain Safety THC Consumption 52

Cannabis Law Report

JUNE 16, 2021

Patients deserve more options, and to be assured of the safety and efficacy of their treatments; similarly, physicians deserve answers and are a critical partner in the development of this new therapeutic class,” says Erin Prosk , President of Santé. ABOUT WAKE NETWORK, INC. Wake Network Inc. ABOUT SANTÉ CANNABIS.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

The Blunt Truth

DECEMBER 9, 2021

Further bulletins as events warrant. The CBD Product Safety and Standardization Act of 2021 would mandate that the Food and Drug Administration regulate CBD as a food ingredient and establish labeling requirements and other standards. The problem is that the VA can’t prescribe medical cannabis for veterans suffering from the condition.

Banking 115

Banking Food CBD Events 115

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

JULY 29, 2021

Our evidence-based scientific approach has enabled us to develop a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. Forward-looking statements. Some statements in this release may contain forward-looking information.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

MMJ Recs

DECEMBER 20, 2023

The establishment of medical marijuana dispensaries in Virginia represents a progressive approach to healthcare, offering patients alternative treatment options for various medical conditions. Patients diagnosed with specific medical conditions are eligible to participate in the state’s medical cannabis program.

Dispensary 52

Dispensary Marijuana Strains Patients 52

MMJ Recs

MARCH 2, 2024

Observing discretion in discussions regarding medical conditions and treatment enhances privacy and respect among patrons. Additionally, adhering to dispensary policies on product handling and consumption promotes harmony and safety. Q: What medical conditions qualify for medical marijuana use in Ohio?

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

TheAnswerPage

AUGUST 4, 2021

Efficacy and safety of add-on cannabidiol (CBD) to treat seizures associated with Lennox Gastaut Syndrome (LGS) was demonstrated in two randomized controlled trials (RCTs). The results are as follows: “Adverse events (AEs) occurred in 96% of patients, serious AEs in 42%, and AE-related discontinuations in 12%.

Safety 52

Safety Patients Events CBD 52

Veriheal

MAY 30, 2023

Cancer Pain Relief With Cannabis: What the New Study Shows Utilizing data from the Quebec Cannabis Registry in Canada, researchers sought to examine the safety and effectiveness of cannabis in addressing cancer pain. Always consult a physician before making any decision on the treatment of a medical condition. Interestingly, 72.5%

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

NOVEMBER 19, 2021

“These additional patent filings are key as PsyBio moves towards the initiation of appropriately approved safety and efficacy clinical trials for our selected compounds within the production and manufacturing arena, for the Company as well as for our investors.” ” About PsyBio Therapeutics Corp.

Clinical Trials 52

Clinical Trials Research and Development Events Safety 52

Cannabis Law Report

JULY 6, 2021

Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety. related to cannabis use and Cannabix Technologies is at the forefront of developing the tools to aid public safety and create more relevant and fairer cannabis testing technology,” stated CEO Rav Mlait.

Research and Development 105

Research and Development THC Safety Events 105

Cannabis Law Report

SEPTEMBER 22, 2022

AB 1885 expands the purpose of the comprehensive system established by Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) to include the control and regulation of the cultivation, distribution, transport, storage, manufacturing, processing, and sale of cannabis products intended for use on, or consumption by, animals.

Law 52

Law Events Packaging Pets 52

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

OCTOBER 20, 2021

This is now the third time in the last 12 months there’s been a major event around extraction in Los Angeles. Business where fire occurred was legal, but the extraction operation had not gone through the permit and safety process. Two proved to be in critical condition and the other in serious condition.

Extraction 52

Extraction Hemp Safety Conditions 52

FloridaMarijuana.net

JULY 8, 2018

The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. When the body is defensive against trauma or illness, this system begins to fail, resulting in physical, mental and/or neurological conditions. 5 cannabis strains to treat PTSD?

Strains 190

Strains Indica Hybrid Research and Development 190

Veriheal

MARCH 18, 2021

Unfortunately, both of these conditions result in cognitive decline and suffer from a lack of effective treatment. This is a pretty common statement in most published research on cannabis as a possible treatment for conditions. Why Aging Cats?

CBD 95

CBD Research and Development Pets Treatment 95

Cannabis Law Report

FEBRUARY 9, 2022

These are the very first draft rules that we’re seeing, so it really is a kind of pivotal event.”. There’s also concern about a rare condition known as wood lover’s paralysis , a condition that produces muscle weakness a few hours after hallucinogenic mushrooms are consumed. Other species might be introduced later.

Clinical Trials 52

Clinical Trials Microdosing Safety Conditions 52

Cannabis Law Report

DECEMBER 3, 2021

Extended Duration Safety and Efficacy of Adjunctive Ganaxolone Treatment in Patients with CDKL5 Deficiency Disorder: 8-Month Minimum Open-Label Extension Follow-up. Safety findings from this OLE analysis are consistent with the safety in the double-blind phase as well as the known safety profile of gananxolone.

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

MMJ Recs

JUNE 25, 2021

On April 17, 2016, Pennsylvania’s governor legalized the use of medical marijuana in the state, and from February 15 th , 2018, those with a need for medical marijuana because of various health conditions were able to purchase and use cannabis legally. Getting a job with a medical card in Pennsylvania.

Conditions 52

Conditions Law Marijuana Events 52

Cannabis Law Report

JUNE 23, 2021

Across all patients, findings are reported in health-related quality of life as well as within specific conditions such as pain, anxiety, and palliative care. Patient Laura Drummond is prescribed medical cannabis for a persistent pain condition fibromyalgia. These patients also reported improved sleep and general quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

MAY 19, 2022

FDA states it has serious safety concerns with delta-8 THC. FDA states it has received 104 reports of adverse events in patients who consumed delta-8 THC products between December 1, 2020 and February 28, 2022. FDA considers delta-8 THC to pose serious health and safety risks. FDA Warning Letters. meat, milk, and eggs).

THC 52

THC CBD Food Pets 52

MMJ Recs

OCTOBER 2, 2023

Today we’re here to explore the best medical marijuana dispensaries in California, as well as provide guidance on how to obtain a medical marijuana card, relevant state laws, the difference between recreational and medical marijuana, regulations governing medical cannabis, qualifying conditions, and the role of medical marijuana doctors.

Dispensary 52

Dispensary Patients Environment Conditions 52

MMJ Recs

APRIL 9, 2024

One of the key advantages of medical marijuana is its ability to provide relief from pain, making it a valuable tool for individuals managing conditions such as arthritis, neuropathy, and multiple sclerosis. Individuals with PTSD may struggle with intrusive memories, flashbacks, and heightened anxiety levels.

Marijuana 52

Marijuana Strains Chronic Pain THC 52

Cannabis Law Report

AUGUST 23, 2021

FDA has not reviewed the manufacturing process of these unapproved CBD-containing drug products, so the manufacturing conditions of, or contaminant levels in, these products is unknown. Practicing veterinarians face a barrage of questions from pet owners about the use of CBD animal products for conditions ranging from arthritis to anxiety.

Pets 105

Pets Hemp CBD Food 105

Cannabis Law Report

AUGUST 27, 2021

Closing of the Private Placement is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including approval of the Toronto Stock Exchange. Each whole Warrant will entitle the holder to acquire one additional Common Share at a price of USD$0.50 HempFusion Wellness Inc.

Research and Development 105

Research and Development Events Hemp Food 105

Medicinal Genomics

JUNE 18, 2020

However, a proactive approach to testing for SARs-CoV-2 in the cannabis supply chain is the only way to test that hypothesis, and thus ensure patient safety and the financial survival of our industry.

Supply Chain 97

Supply Chain Patients Medicine Hemp 97

Cannabis Law Report

JUNE 16, 2021

With increased capacity to screen patients, on a genetic basis, for underlying psychiatric disorders prior to undertaking PAP, Entheon is furthering its commitment toward safety and predictability in psychedelic therapies while aggregating data that can be used to determine which psychedelic molecules are best-suited for a particular patient.”

Research and Development 105

Research and Development Data Conditions Events 105

Cannabis Law Report

SEPTEMBER 19, 2019

Any forward-looking information and statements speak only as of the date on which they are made, and, except as required by law, CannTrust does not undertake any obligation to update or revise any forward-looking information or statements, whether as a result of new information, future events or otherwise.

Compliance 55

Compliance Compliance Events Research and Development 55

Cannabis Law Report

MAY 6, 2022

The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products.

THC 52

THC CBD Media Food 52

Cannabis Law Report

AUGUST 3, 2021

Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements.

Clinical Trials 105

Clinical Trials Events Treatment Banking 105

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma’s objective is to create and leverage a proprietary drug development platform in collaboration with an artificial intelligence and machine learning group to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific disease states and conditions.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Canna Law Blog

JULY 14, 2023

. §§ 52, 55(a)(1) (under Section 12 of the FTC Act, which prohibits false advertisements for foods and drugs, the Commission must consider any consequences that may result from the use of the product under customary or usual conditions). Ingesting edible cannabis products can result in serious health consequences in children.3

Packaging 74

Packaging Food Edibles THC 74